IFNγ and CXCR-1 gene polymorphisms in idiopathic bronchiectasis

Tissue Antigens

Volumn 68, Issue 4, 2006, Pages 325-330

  Boyton, R J ^a,b   Reynolds, C ^a   Wahid, F N ^c   Jones, M G ^d   Ozerovitch, L ^b   Ahmad, T ^e   Chaudhry, A ^f   Jewell, D P ^e   Kon, O M ^g   Smith, J ^h   Rose, M ^h   Newman Taylor, A J ^d   Cole, P ^b   Wilson, R ^b   Altmann, D M ^c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^h HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

Bronchiectasis; CXC receptor 1; Human genetics; Interferon ; Ulcerative colitis

Indexed keywords

ADENINE; CHEMOKINE RECEPTOR CXCR1; CYTOSINE; GAMMA INTERFERON; GUANINE; INTERLEUKIN 8; THYMINE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BRONCHIECTASIS; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; HUMAN; IDIOPATHIC BRONCHIECTASIS; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN BINDING; RESPIRATORY TRACT INFLAMMATION; SYMPTOMATOLOGY; ULCERATIVE COLITIS;

ALLELES; BRONCHIECTASIS; COLITIS, ULCERATIVE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERFERON TYPE II; INTERFERON-GAMMA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-8A;

BACTERIA (MICROORGANISMS);

EID: 33749558416     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.00670.x     Document Type: Article

References (36)

1. Wilson R. Bronchiectasis. In: Gibson GJ, Geddes DM, Costabel U, Sterk PJ, Corrin B., eds. Respiratory Medicine, 3rd edn, Vol. 2. London: Saunders/Elsevier, 2003, 1445-64.
2. Cohen M, Sahn SA. Bronchiectasis in systemic disease. Chest 1999: 116: 1063-74.
3. Boyton RJ, Openshaw PJ. Pulmonary defences to acute respiratory infection. Br Med Bull 2002: 61: 1-12.
4. + T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis. Thorax 1998: 53: 685-91.
5. Silva JR, Jones JA, Cole PJ, Poulter LW. The immunological component of the cellular inflammatory infiltrate in bronchiectasis. Thorax 1989: 44: 668-73.
6. Hourk R. Chemokine receptors. Cytokine Growth Factor Rev 2001: 12: 313-35.
7. Holmes WE, Lee J, Kuang WJ, Rice GC, Wood, WI. Structure and functional expression of a human interleukin-8 receptor. Science 1991: 253: 1278-80.
8. Murphy PM, Tiffany HL. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 1991: 253: 1280-3.
9. Lee J, Horuk R, Rice GC, Bennett GL, Camerato T, Wood WI. Characterization of two high affinity human interleukin-8 receptors. J Biol Chem 1992: 267: 16283-7.
10. Morohashi H, Miyawaki T, Nomura H. Expression of both types of human interleukin-8 receptors on mature neutrophils, monocytes, and natural killer cells. J Leukoc Biol 1995: 57: 180-7.
11. Hébert CA, Chuntharapai A, Smith M, Colby T, Kim J, Horuk R. Partial functional mapping of the human interleukin-8 type A receptor. Identification of a major ligand binding domain. J Biol Chem 1993: 268: 18549-53.
12. Renzoni E, Lympany P, Sestini P et al. Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthritis Rheum 2000: 43: 1633-40.
13. Farrell RJ, Peppercorn MA. Ulcerative colitis. Lancet 2002: 359: 331-40.
14. Papadakis KA, Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med 2000: 51: 289-98.
15. Williams EJ, Haque S, Banks C, Johnson P, Sarsfield P, Sheron N. Distribution of the interleukin-8 receptors, CXCR1 and CXCR2, in inflamed gut tissue. J Pathol 2000: 192: 533-9.
16. Singh B, Read S, Asseman C et al. Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001: 182: 190-200.
17. Blumberg RS, Saubermann LJ, Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 1999: 11: 648-56.
18. Dohi T, Fujihashi K, Rennert PD, Iwatani K, Kiyono H, McGhee JR. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. J Exp Med 1999: 189: 1169-79.
19. Newport MJ, Huxley CM, Huston S et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996: 335: 1941-9.
20. Pravica V, Asderakis A, Perry C, Hajeer A, Sinnott PJ, Hutchinson IV. In vitro production of IFN-γ correlates with CA repeat polymorphism in the human IFN- γ gene. Eur J Immunogenetics 1999: 26: 1-3.
21. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV. A single nucleotide polymorphism in the first intron of the human IFN-γ gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-γ production. Hum Immunol 2000: 61: 863-6.
22. Awad M, Pravica V, Perrey C et al. CA repeat allele polymorphism in the first intron of human interferon-γ gene is associated with lung allograft fibrosis. Hum Immunol 1999: 60: 343-6.
23. Lopez-Maderuelo D, Arnalich F, Serantes R et al. Interferon-γ and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med 2003: 167: 970-5.
24. British Thoracic Society. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997: 52 (Suppl. 5): S4-6.
25. Arkwright PD, Pravica V, Geraghty PJ et al. End-organ dysfunction in cystic fibrosis: association with angiotensin I converting enzyme and cytokine gene polymorphism. Am J Respir Crit Care Med 2003: 167: 384-9.
26. Warle MC, Farhan A, Metselaar HJ et al. Are cytokine gene polymorphisms related to in vitro cytokine production profiles? Liver Transpl 2003: 9: 170-81.
27. Boyton RJ, Smith J, Ward R et al. HLA-C and killer cell immunoglobulin-like receptor (KIR) genes in idiopathic bronchiectasis. Am J Respir Crit Care Med 2005: 173: 327-33.
28. Angrill J, Agusti C, Celis RD et al. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. Am J Respir Crit Care Med 2001: 164: 1628-32.
29. Gadola SD, Moins-Teisserenc HT, Trowsdale J, Gross WL, Cerundolo V. TAP deficiency syndrome. Clin Exp Immunol 2000: 121: 173-8.
30. Pasteur MC, Helliwell SM, Houghton SJ et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 2000: 162: 1277-84.
31. Mahadeva R, Walsh G, Flower CDR, Shneerson JM. Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J 2000: 15: 41-8.
32. Songur N, Songur Y, Tuzun M et al. Pulmonary function tests and high resolution CT in the detection of pulmonary involvement in inflammatory bowel disease. J Clin Gastroenterol 2003: 37: 292-8.
33. Marvisi M, Bassi E, Civardi G. Pulmonary involvement in inflammatory bowel disease. Curr Drug Targets Inflamm Allergy 2004: 3: 437-9.
34. Butland RJ, Cole P, Citron KM, Turner-Warrick M. Chronic bronchial suppuration and inflammatory bowel disease. Q J Med 1981: 50: 63-75.
35. Camus P, Piard F, Ashcroft T, Gal AA, Colby TV. The lung and inflammatory bowel disease. Medicine 1993: 72: 151-83.
36. Logan RFA. Inflammatory bowel disease incidence: up, down or unchanged? Gut 1998: 42: 309-11.